Skip to main content
    G

    Globus Medical (GMED)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $78.87
    +2.56 (+3.35%)

    Market Cap: $10.25B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    79%(31/39)
    Avg Surprise
    +13.89%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.20
    Range$1.13 - $1.26
    14 analysts
    EPS Revisions
    1
    0
    7d
    9
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$1.17+2.2%
    60d ago$1.19+0.7%
    30d ago$1.200.0%
    7d ago$1.200.0%
    Current$1.20
    Revenue Consensus
    $792M
    Range$776M - $813M
    15 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.79
    Range$1.75 - $1.83
    15 analysts
    Revenue Consensus
    $883M
    Range$864M - $900M
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.79---
    Sep 26EST
    		-$1.20---
    Jun 26
    Reported Aug 6
    		$1.34$1.12+19.64%Beat+55.8%
    Mar 26
    Reported May 7
    		$1.12$0.92+21.74%Beat+64.7%
    Dec 25
    Reported Feb 24
    		$1.28$1.15+10.96%Beat+52.4%
    Sep 25
    Reported Nov 6
    		$1.18$0.78+51.28%Beat+42.2%
    Jun 25
    Reported Aug 7
    		$0.86$0.76+13.16%Beat+14.7%
    Mar 25
    Reported May 8
    		$0.68$0.75-9.33%Miss-5.6%
    Dec 24
    Reported Feb 20
    		$0.84$0.75+12.21%Beat+40.0%
    Sep 24
    Reported Nov 5
    		$0.83$0.65+27.69%Beat+45.6%
    Jun 24
    Reported Aug 6
    		$0.75$0.68+10.29%Beat+19.0%
    Mar 24
    Reported May 7
    		$0.72$0.57+26.32%Beat+35.8%
    Dec 23
    Reported Feb 20
    		$0.60$0.61-1.64%Miss+1.7%
    Sep 23
    Reported Nov 7
    		$0.57$0.57+0.00%Beat+14.0%
    Jun 23
    Reported Aug 3
    		$0.63$0.59+6.78%Beat+12.5%
    Mar 23
    Reported May 4
    		$0.53$0.51+3.92%Beat+26.2%
    Dec 22
    Reported Feb 21
    		$0.59$0.56+5.36%Beat+20.4%
    Sep 22
    Reported Nov 8
    		$0.50$0.52-3.85%Miss+0.0%
    Jun 22
    Reported Aug 4
    		$0.56$0.53+5.66%Beat+0.0%
    Mar 22
    Reported May 10
    		$0.42$0.47-10.64%Miss-14.3%
    Dec 21
    Reported Feb 17
    		$0.49$0.47+4.26%Beat-15.5%
    Sep 21
    Reported Nov 4
    		$0.50$0.45+11.11%Beat+2.0%
    Jun 21
    Reported Aug 4
    		$0.56$0.44+27.27%Beat+700.0%
    Mar 21
    Reported May 4
    		$0.49$0.37+32.43%Beat+69.0%
    Dec 20
    Reported Feb 17
    		$0.58$0.51+13.73%Beat+18.4%
    Sep 20
    Reported Oct 28
    		$0.49$0.31+58.06%Beat+14.0%
    Jun 20
    Reported Aug 5
    		$0.07$-0.11+163.64%Beat-82.9%
    Mar 20
    Reported May 7
    		$0.29$0.38-23.68%Miss-19.4%
    Dec 19
    Reported Feb 20
    		$0.49$0.52-5.77%Miss+14.0%
    Sep 19
    Reported Nov 6
    		$0.43$0.42+2.38%Beat+10.3%
    Jun 19
    Reported Aug 1
    		$0.41$0.41+0.00%Beat-6.8%
    Mar 19
    Reported May 2
    		$0.36$0.41-12.20%Miss-12.2%
    Dec 18
    Reported Feb 21
    		$0.43$0.39+10.26%Beat+13.2%
    Sep 18
    Reported Nov 8
    		$0.39$0.32+21.88%Beat+30.0%
    Jun 18
    Reported Aug 1
    		$0.44$0.35+25.71%Beat+37.5%
    Mar 18
    Reported May 2
    		$0.41$0.36+13.89%Beat+36.7%
    Dec 17
    Reported Feb 21
    		$0.38$0.35+8.57%Beat+22.6%
    Sep 17
    Reported Nov 8
    		$0.30$0.30+0.00%Beat-
    Jun 17
    Reported Aug 2
    		$0.32$0.30+6.67%Beat-
    Mar 17
    Reported May 3
    		$0.30$0.30+0.00%Beat-
    Dec 16
    Reported Feb 27
    		$0.31$0.33-6.06%Miss-

    Key Metrics

    Valuation
    P/E Ratio16.03EV/EBITDA10.84x
    Price/FCF14.10xFCF Yield7.09%
    Profitability
    Profit Margin17.00%Operating Margin24.80%
    ROE11.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio4.62xQuick Ratio2.93x
    Trading Statistics
    Beta0.96Avg Volume1.57M
    52-Week High$101.4052-Week Low$58.51

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$75.81
    SMA 20$75.21
    SMA 50$78.81
    SMA 200$84.11
    EMA 10$76.10
    EMA 20$75.97
    EMA 50$77.42
    EMA 200$79.80

    MACD

    Line: -0.24Signal: -0.82Hist: 0.58

    ADX

    ADX: 15.6+DI: 27.7-DI: 17.3

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down80.0
    PSAR$72.54

    Bollinger Bands

    Upper Band$77.83
    Lower Band$72.59
    %B Position696%(Upper)
    Band Width1.20

    RSI (14-Day)

    Neutral
    60.1

    Momentum Oscillators

    Stoch %K80.5
    Stoch %D72.1
    Williams %R-6.1
    ROC (10d)6.0%
    Momentum4.46
    CCI (20d)255.3
    MFI (14d)66.9

    Volatility Measures

    ATR (14d)$1.97(2.5%)
    StdDev (20d)1.31
    Hist Vol23.5%(Moderate)

    Volume Flow

    VWAP$78.40
    OBV-11.4M
    AD Line2.6M
    CMF (20d)0.091

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio1.2x
    VWMA (20d)$75.10

    Pivot Points

    R3$78.58
    R2$77.66
    R1$76.98
    Pivot Point$76.06
    S1$75.38
    S2$74.46
    S3$73.78

    Advanced Oscillators

    TSI-4.10
    Ultimate Osc59.7
    KST-34.12

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$789.61M$759.85M$826.42M$769.05M$745.34M$598.12M$657.29M$625.71M$629.69M$606.67M$616.53M$383.64M
    Cost of Revenue$241.44M$234.07M$261.11M$252.53M$248.76M$195.40M$263.44M$270.51M$260.04M$241.49M$265.49M$135.39M
    Gross Profit$548.17M$525.79M$565.31M$516.51M$496.58M$402.72M$393.86M$355.19M$369.65M$365.18M$351.05M$248.25M
    Operating Expenses$365.74M$375.40M$395.97M$379.15M$420.47M$305.72M$333.58M$307.09M$320.03M$357.18M$340.93M$247.84M
    R&D$36.32M$36.51M$36.16M$38.07M$39.95M$33.06M$33.41M$35.38M$37.70M$57.27M$52.25M$29.33M
    SG&A$286.82M$297.77M$318.48M$313.60M$303.62M$242.80M$253.17M$240.06M$239.45M$248.68M$245.15M$156.21M
    Operating Income$182.43M$150.39M$169.34M$137.36M$76.11M$97.00M$60.27M$48.10M$49.62M$8.00M$10.12M$404,000
    Interest Income$7.07M$5.43M$0$0$693,000$1.68M$0$0$0$0$0$0
    Interest Expense$0$0$107,000$-1,455,000$0$0$35.61M$775,000$2.33M$1.89M$0$-7,920,000
    Income Before Tax$189.82M$157.07M$169.23M$143.99M$188.17M$103.67M$24.67M$57.03M$47.58M$-8,558,000$25.00M$2.54M
    Income Tax Expense$38.25M$32.77M$28.64M$25.03M$-14,673,000$28.21M$-1,838,000$5.20M$15.82M$-1,441,000$9.96M$1.54M
    Net Income$151.57M$124.30M$140.59M$118.97M$202.85M$75.46M$26.50M$51.84M$31.76M$-7,117,000$15.03M$998,000
    EBITDA$252.24M$221.50M$241.89M$220.57M$264.08M$174.35M$145.54M$192.06M$173.79M$108.95M$159.57M$51.01M
    EBIT$182.74M$151.64M$165.92M$142.54M$187.48M$101.99M$23.85M$57.81M$49.92M$-6,664,000$27.58M$-5,385,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Globus Medical Grew Earnings 56% On 6% Revenue. The Robotics Line Went Backwards.

    Q2 non-GAAP EPS $1.34, up 55.8% y/y; revenue $789.6M, +5.9%; company kept revenue guide $3.18-3.22B and raised adjusted EPS to $4.95-5.05 from $4.70-4.80 Enabling Technologies revenue fell 25.8% to $26.1M, now 3.3% of sales - robotics is a marginal, shrinking contributor...

    Glenn Ford
    •
    8/11/26
    •
    201
    Medical Devices, value investing
    Also mentions:
    MDTISRG

    Government Contracts

    Gov Obligations (TTM)
    $9453
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    145
    New Awards (TTM)
    136
    Avg Remaining Term
    6.0 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25725C0056Department of Veterans AffairsDepartment of Veterans Affairs$231000Sep 19, 2025
    HT941026PE042Department of DefenseDefense Health Agency$64186Feb 20, 2026
    HT941026PE024Department of DefenseDefense Health Agency$61379Jan 15, 2026
    SPE2D625F0ZEXDepartment of DefenseDefense Logistics Agency$44763Aug 14, 2025
    SPE2D626F05TKDepartment of DefenseDefense Logistics Agency$42475Jan 13, 2026
    SPE2D625F1WRZDepartment of DefenseDefense Logistics Agency$34092Aug 5, 2025
    HT940625PE017Department of DefenseDefense Health Agency$32065Sep 22, 2025
    SPE2D626F30QEDepartment of DefenseDefense Logistics Agency$31415Jan 28, 2026
    HT001425PE042Department of DefenseDefense Health Agency$29522Sep 15, 2025
    SPE2D626F26JHDepartment of DefenseDefense Logistics Agency$27380Jan 22, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    How Globus Medical Inc. Class A (GMED) Affects Rotational Strategy Timing

    This article analyzes Globus Medical Inc. Class A (GMED) using AI models, highlighting a weak near-term sentiment and a mid-channel oscillation pattern. It outlines three distinct institutional trading...

    Stock Traders Daily•10/12/26•Neutral

    Basic earnings per share (basic EPS) of Globus Medical Inc Class A – HAN:GM0N

    This page provides basic earnings per share (EPS) information for Globus Medical Inc Class A, trading under the ticker GM0N on the Hannover Stock Exchange. The article focuses solely on financial data...

    TradingView•9/30/26•Neutral

    How (GMED) Movements Inform Risk Allocation Models

    This article analyzes Globus Medical Inc. Class A (GMED) stock, noting a weak near-term sentiment despite long-term strength. It highlights an exceptional 59.8:1 risk-reward setup targeting a 17.4% gain with minimal...

    Stock Traders Daily•8/31/26•Bullish

    Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions

    Globus Medical, a musculoskeletal technology company, has acquired Higgs Boson Health, a digital healthcare experience company specializing in AI-driven solutions. This acquisition aims to enhance the patient...

    Yahoo Finance•8/26/26•Bullish

    Globus Medical (GMED) Could Be 17% Undervalued On Its Robotics Growth Narrative

    Globus Medical (GMED) is considered potentially undervalued despite strong historical returns and a P/E ratio below industry averages...

    Sahm•8/22/26•Somewhat-Bullish

    GMED Valuation and Fair Value

    P/E
    16.0x
    Forward P/E
    13.9x
    EV/EBITDA
    10.8x
    P/FCF
    14.1x
    PEG
    1.7x
    P/B
    2.2x
    See GNG's fair value

    GMED Profitability: Margins, ROIC and FCF

    Gross margin
    68.5%
    Operating margin
    24.8%
    Net margin
    17.0%
    ROE
    11.8%
    FCF margin
    24.0%
    FCF yield
    7.1%

    GMED Competitors

    CompanyTicker
    Align Technology IncALGN
    Apogee Therapeutics, Inc. Common StockAPGE
    Madrigal Pharmaceuticals IncMDGL
    The Ensign Group IncENSG
    Immunitybio IncIBRX
    Twist Bioscience CorpTWST
    Oscar Health IncOSCR
    Bio-Rad Laboratories IncBIO-B

    Sector: Healthcare

    GMED Analyst Ratings

    Consensus
    Buy
    Analysts
    15
    Strong Buy
    3
    Buy
    7
    Hold
    5
    Sell
    0
    Strong Sell
    0

    GMED Bull Case vs Bear Case

    Bull case

    • GMED converts 24.0% of revenue into free cash flow.
    • GMED beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 66.7% of GMED's analyst ratings are Buy or Strong Buy.

    GMED Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    18.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.20
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    9 up, 0 down

    Frequently Asked Questions About GMED

    Does GMED pay dividends?

    Globus Medical (GMED) does not currently pay a regular dividend.

    What is GMED's P/E ratio?

    Globus Medical has a price-to-earnings (P/E) ratio of 16.03.

    What is GMED's market cap?

    Globus Medical (GMED) has a market capitalization of $10.25B with a current stock price of $78.87.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In